Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 11
- Labeller names
- 2
- Live patents
- 0
- Shortage listings
- 4
- Countries
- 0
Alert
Drug shortage listings
4| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Sodium Acetate InjectionTotal Parenteral Nutrition | Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Current | Available | 23 Mar 20161 Oct 2026 |
| Sodium Acetate InjectionEndocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition | Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Current | Limited Availability | 3 Feb 20161 Oct 2026 |
| Sodium Acetate InjectionTotal Parenteral Nutrition | Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Current | Available | 23 Mar 20161 Oct 2026 |
| Sodium Acetate InjectionEndocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Current | Available | 3 Feb 20161 Oct 2026 |
Catalogue
Drug listings by form and route
1111 active NDC listings: 11 human prescription drug. By marketing category: ANDA 11.
| Dosage form | NDCs |
|---|---|
| injection, solution | 5 |
| injection, solution, concentrate | 4 |
| injection, powder, lyophilized, for solution | 2 |
| Route | NDCs |
|---|---|
| intravenous | 11 |
| intramuscular | 1 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| milla pharmaceuticals inc. | 7 |
| milla pharmaceuticals inc. | 4 |
Catalogue
Marketed products
11| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Dihydroergotamine Mesylate | Dihydroergotamine Mesylate | injection, solution, intramuscular, intravenous, subcutaneous | 71357-013ANDA |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN AND TAZOBACTAM | injection, powder, lyophilized, for solution, intravenous | 71357-022ANDA |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN AND TAZOBACTAM | injection, powder, lyophilized, for solution, intravenous | 71357-023ANDA |
| Sodium Acetate | Sodium Acetate | injection, solution, concentrate, intravenous | 71357-002ANDA |
| Sodium Acetate | Sodium Acetate | injection, solution, concentrate, intravenous | 71357-007ANDA |
| Sodium Acetate | Sodium Acetate Injection, USP, 200 mEq/100 mL | injection, solution, concentrate, intravenous | 71357-008ANDA |
| Sodium Acetate | Sodium Acetate Injection, USP, 400 mEq/100 mL | injection, solution, concentrate, intravenous | 71357-009ANDA |
| Sodium Bicarbonate | Sodium Bicarbonate | injection, solution, intravenous | 71357-004ANDA |
| Tranexamic Acid | Tranexamic Acid | injection, solution, intravenous | 71357-017ANDA |
| Tranexamic Acid | Tranexamic Acid | injection, solution, intravenous | 71357-018ANDA |
| Tromethamine | Tromethamine | injection, solution, intravenous | 71357-001ANDA |
Enquiry
Common questions
- Is Milla Pharmaceuticals Inc. FDA approved?
- Milla Pharmaceuticals Inc. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Milla Pharmaceuticals Inc. make?
- 11 products are listed under Milla Pharmaceuticals Inc. in the openFDA NDC Directory, most often as injection, solution; injection, solution, concentrate; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Milla Pharmaceuticals Inc. products in shortage?
- 4 presentations are currently listed in the FDA drug shortage database under Milla Pharmaceuticals Inc., covering Sodium Acetate Injection.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.